Mesa Laboratories, Inc.
MLAB
$92.77
$1.571.72%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 46.61% | -47.79% | 166.66% | -324.46% | -148.89% |
| Total Depreciation and Amortization | -2.29% | -1.81% | -20.54% | 36.38% | -9.41% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -7.86% | 725.15% | -132.94% | -75.84% | 502.97% |
| Change in Net Operating Assets | 182.31% | 31.48% | -182.09% | 171.85% | 159.31% |
| Cash from Operations | 128.10% | 334.34% | -85.05% | -30.14% | 243.94% |
| Capital Expenditure | 32.97% | -8.23% | -33.29% | 6.89% | 54.53% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 32.97% | -8.23% | -0.20% | -23.86% | 54.53% |
| Total Debt Issued | -100.00% | 823.81% | -- | -- | -- |
| Total Debt Repaid | 91.60% | -1,290.66% | 58.53% | -90.06% | -26.91% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -0.23% | -1.03% | -0.34% | -0.12% | -0.35% |
| Other Financing Activities | 62.06% | 94.69% | -1,337.30% | 4,190.00% | 106.51% |
| Cash from Financing | -24.13% | 6.46% | 47.96% | -57.41% | -19.48% |
| Foreign Exchange rate Adjustments | 403.85% | -106.93% | 66.78% | 319.51% | -141.33% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1,098.02% | 85.82% | -66.22% | -154.92% | 260.07% |